Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Psychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1007/BF00441953PMID 2570434
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A simple and reliable conflict procedure for testing anti-anxiety agents

  2004cited by this paper
• Autonomic and psychic effects of yohimbine hydrochloride

  2004cited by this paper
• Anticonflict and rotarod impairing effects of alprazolam and diazepam in rat after acute and subchronic administration.

  1989cited by this paper
• Neuropeptide Y (NPY) and the central nervous system: distribution effects and possible relationship to neurological and psychiatric disorders.

  1989cited by this paper
• Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with alpha-adrenoceptors.

  1988cited by this paper
• Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain.

  1988cited by this paper
• Biphasic effects of clonidine on conflict behavior: involvement of different alpha-adrenoceptors.

  1988cited by this paper
• Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively.

  1988cited by this paper
• Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with α-adrenoceptors

  1988cited by this paper
• Neuropeptide Y receptors and the inhibition of adenylate cyclase in the human frontal and temporal cortex.

  1987cited by this paper
• Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat.

  1987cited by this paper
• Modulation of memory processing by neuropeptide Y.

  1987cited by this paper
• Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat.

  1987cited by this paper
• Antidepressant drugs in anxiety disorders

  1987cited by this paper
• Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the rat.

  1987cited by this paper
• Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides.

  1986cited by this paper
• Neurotransmitters, anxiety and benzodiazepines: a behavioral review.

  1986cited by this paper
• Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.

  1986cited by this paper
• Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

  1985cited by this paper
• Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

  1984cited by this paper
• Neuropeptide Y: a potent inducer of consummatory behavior in rats.

  1984cited by this paper
• Norepinephrine-like effects of neuropeptide Y on LH release in the rat.

  1984cited by this paper
• Avian pancreatic polypeptide phase shifts hamster circadian rhythms when microinjected into the suprachiasmatic region.

  1984cited by this paper
• Actions of centrally administered neuropeptide Y on EEG activity in different rat strains and in different phases of their circadian cycle.

  1984cited by this paper
• Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ‘fear’-motivated behaviour

  1984cited by this paper
• Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat.

  1984cited by this paper
• Neuropeptide Y receptor in the rat brain.

  1984cited by this paper
• Metabolism of caffeine by mouse liver microsomes: GSH or cytosol causes a shift in products from 1,3,7-trimethylurate to a substituted diaminouracil.

  1983cited by this paper
• Neuropeptide Y distribution in human brain

  1983cited by this paper
• Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat.

  1983cited by this paper
• Neuropharmacological studies in rodents on the action of RX 781094, a new selective alpha 2-adrenoceptor antagonist.

  1983cited by this paper
• Neuropeptide Y in vitro selectivity increases the number of alpha 2-adrenergic binding sites in membranes of the medulla oblongata of the rat.

  1983cited by this paper
• Neurotransmitters in anxiety.

  1982cited by this paper
• Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function.

  1982cited by this paper
• Effects of clonidine on anxiety disorders.

  1981cited by this paper
• Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides

  1980cited by this paper
• Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety.

  1979cited by this paper
• α2‐ADRENOCEPTORS MEDIATE CLONIDINE‐INDUCED SEDATION IN THE RAT

  1979cited by this paper
• Plasma corticosterone and brain catecholamines in stress: effect of psychotropic drugs.

  1977cited by this paper
• Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine.

  1975cited by this paper
• The relation between fear induced by novel stimulation and exploratory behavior.

  1955cited by this paper
• The relation between fear induced by novel stimulation and exploratory drive.

  1955cited by this paper

• Role of interplay between endocannabinoids and neuropeptides in pathogenesis and therapy of depressive and anxiety disorders.

  2025cites this paper
• Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 Administration to Long-Evans Rats Has Interactive Effects with Sex and Diet on Anxiety-Related Feeding Behaviors and Specific Endocrine Outcomes.

  2025cites this paper
• Modulating neuropeptide Y pathways to combat nicotine addiction through emerging evidence and future directions.

  2025cites this paper
• Neuropeptides as transmitters and regulators of the locus coeruleus noradrenergic system

  2025cites this paper
• Nanoparticle‐encapsulated neuropeptide Y provides robust seizure protection in SCN1A‐derived epilepsy

  2025cites this paper
• Neuropeptide Y in cancer—biological functions and potential clinical implications

  2025cites this paper
• Neuropeptide Y Y1 receptor localization in mouse brain tissue revealed by an antibody with "hard specificity criterion".

  2025cites this paper
• Modulation of temporoammonic-CA1 synapses by neuropeptide Y is through Y1 receptors in mice.

  2025cites this paper
• Suicide risk genes impact evolutionarily conserved survival strategies

  2025cites this paper
• Neuropeptide Y neurons surrounding the locus coeruleus inhibit noradrenergic system activity to reduce anxiety

  2025cites this paper
• Potentiation of antidepressant effects: NPY1R agonist and ketamine synergy enhances TrkB signaling and neurogenesis in the ventral hippocampus

  2024cites this paper
• Valence-dependent effects of neuropeptide Y on the expression of conditioned fear and anxiety-like behavior: Involvement of the bed nucleus of the stria terminalis.

  2024cites this paper
• Feedforward inhibition of stress by brainstem neuropeptide Y neurons

  2024cites this paper
• NPYR modulation: Potential for the next major advance in obesity and type 2 diabetes management?

  2024cites this paper
• NPY-mediated synaptic plasticity in the extended amygdala prioritizes feeding during starvation

  2024cites this paper
• Modulation of Temporoammonic-CA1 Synapses by Neuropeptide Y is Through Y1 Receptors

  2024cites this paper
• Enhanced neuronal survival and BDNF elevation via long-term co-activation of galanin 2 (GALR2) and neuropeptide Y1 receptors (NPY1R): potential therapeutic targets for major depressive disorder

  2024cites this paper
• Long‐term enhancements in antidepressant efficacy and neurogenesis: Effects of intranasal co‐administration of neuropeptide Y 1 receptor (NPY1R) and galanin receptor 2 (GALR2) agonists in the ventral hippocampus

  2024cites this paper
• Autoimmune demyelination alters hypothalamic transcriptome and endocrine function

  2024cites this paper
• Potential benefits of intranasal neuropeptide Y include sustained extinction of fear memory

  2023cites this paper
• Cross talk about the role of Neuropeptide Y in CNS disorders and diseases.

  2023cites this paper
• Hunting for Genes Underlying Emotionality in the Laboratory Rat: Maps, Tools and Traps

  2022cites this paper
• Neuropeptide signaling and addiction: what have learned from Drosophila?

  2022cites this paper
• Neuropeptides in psychiatry

  2022cites this paper
• Early life stress and the role of environmental and molecular moderators in the ontology of pathological and resilient behavioral phenotypes

  2022cites this paper
• Neuropeptide System Regulation of Prefrontal Cortex Circuitry: Implications for Neuropsychiatric Disorders

  2022cites this paper
• Adolescent binge-like alcohol exposure dysregulates NPY and CGRP in rats: Behavioural and immunochemical evidence.

  2022cites this paper
• The impact of adolescent nicotine exposure on alcohol use during adulthood: The role of neuropeptides.

  2022cites this paper
• Lateral habenula-projecting central amygdala circuits expressing GABA and NPY Y1 receptor modulate binge-like ethanol intake in mice

  2022cites this paper
• Brain Region-Dependent Effects of Neuropeptide Y on Conditioned Social Fear and Anxiety-Like Behavior in Male Mice

  2021cites this paper
• Neuropeptide Y Reduces Social Fear in Male Mice: Involvement of Y1 and Y2 Receptors in the Dorsolateral Septum and Central Amygdala

  2021cites this paper
• Artificial Intelligence Identified Resilient and Vulnerable Female Rats After Traumatic Stress and Ethanol Exposure: Investigation of Neuropeptide Y Pathway Regulation

  2021cites this paper
• CRISPR knockdown of Kcnq3 attenuates the M-current and increases excitability of NPY/AgRP neurons to alter energy balance

  2021cites this paper
• Effect of depression and suicidal behavior on neuropeptide Y (NPY) and its receptors in the adult human brain: A postmortem study.

  2021cites this paper
• Effect of intranasal administration of neuropeptide Y and single prolonged stress on food consumption and body weight in male rats.

  2020cites this paper
• Neuropeptide Y and amygdala circuitry: Modulation of stress-related behavior

  2020cites this paper
• A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder

  2020cites this paper
• Türkiye Örnekleminde Nöropeptit Y Geni (NPY) Promotor Polimorfizmleri ve Alkol Bağımlılığı Arasındaki İlişki 2

  2020cites this paper
• Nanoparticle encapsulated oxytocin increases resistance to induced seizures and restores social behavior in Scn1a-derived epilepsy.

  2020cites this paper
• CRISPR Knockdown of Kcnq3 Attenuates the M-current in NPY/AgRP Neurons

  2020cites this paper
• Increase in neuropeptide Y activity impairs social behaviour in association with glutamatergic dysregulation in diabetic mice

  2020cites this paper
• Overexpression of neuropeptide Y decreases responsiveness to neuropeptide Y.

  2019cites this paper
• Activation of NPY receptor subtype 1 by [D-His26]NPY is sufficient to prevent development of anxiety and depressive like effects in the single prolonged stress rodent model of PTSD.

  2019cites this paper
• Are neuropeptides relevant for the mechanism of action of SSRIs?

  2019cites this paper
• Neuropeptide Y – Its role in human performance and extreme environments

  2019cites this paper
• Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions

  2019cites this paper
• Neuroendocrinological treatment targets for posttraumatic stress disorder

  2019cites this paper
• Pharmacogenomic assessment of herbal drugs in affective disorders.

  2019cites this paper
• Environmental stressors and alcoholism development: Focus on molecular targets and their epigenetic regulation.

  2019cites this paper
• Role of hypothalamus‐pituitary‐adrenal axis modulation in the stress‐resilient phenotype of DPP4‐deficient rats

  2019cites this paper
• Actions of Neuropeptide Y on Synaptic Transmission in the Lateral Habenula.

  2019cites this paper
• Ultrastructural Characterization of Corticotropin-Releasing Factor and Neuropeptide Y in the Rat Locus Coeruleus: Anatomical Evidence for Putative Interactions.

  2018cites this paper
• Maternal Deprivation Increases Anxiety- and Depressive-Like Behaviors in an Age-Dependent Fashion and Reduces Neuropeptide Y Expression in the Amygdala and Hippocampus of Male and Female Young Adult Rats

  2018cites this paper
• Gene therapy mediated seizure suppression in Genetic Generalised Epilepsy: Neuropeptide Y overexpression in a rat model.

  2018cites this paper
• Essential Role of Histone Methyltransferase G9a in Rapid Tolerance to the Anxiolytic Effects of Ethanol.

  2018cites this paper
• First Behavioural Characterisation of a Knockout Mouse Model for the Transforming Growth Factor (TGF)-β Superfamily Cytokine, MIC-1/GDF15

  2017cites this paper
• Neuropeptide Y in Alcohol Addiction and Affective Disorders

  2017cites this paper
• Analgesic and anxiolytic effects of [Leu31,Pro34]-neuropeptide Y microinjected into the periaqueductal gray in rats.

  2017cites this paper
• Affectives disorders , stress and neuro-inflammation

  2017cites this paper
• A closer look at the subordinate population within the visible burrow system.

  2017cites this paper
• Neuropeptide Y expression confers benzo[a]pyrene induced anxiolytic like behavioral response during early adolescence period of male Wistar rats.

  2017cites this paper
• Peptide YY (3-36) modulates intracellular calcium through activation of the phosphatidylinositol pathway in hippocampal neurons.

  2017cites this paper
• Potential of neuropeptide Y for preventing or treating post-traumatic stress disorder.

  2016cites this paper
• Genetic expression analysis of E2F-associated phosphoprotein in stress responses in the mouse.

  2016cites this paper
• Neuroendocrine Regulation of Anxiety: Beyond the Hypothalamic‐Pituitary‐Adrenal Axis

  2016cites this paper
• Npy deletion in an alcohol non-preferring rat model elicits differential effects on alcohol consumption and body weight.

  2016cites this paper
• Rodent models and mechanisms of voluntary binge-like ethanol consumption: Examples, opportunities, and strategies for preclinical research.

  2016cites this paper
• Neuropeptide systems and new treatments for nicotine addiction

  2016cites this paper
• Environmental enrichment induces behavioural disturbances in neuropeptide Y knockout mice

  2016cites this paper
• Maternal deprivation alters growth, food intake, and neuropeptide Y in the hypothalamus of adolescent male and female rats.

  2016cites this paper
• Neuropeptide Y: A stressful review.

  2016cites this paper
• Neuropeptides : Active neuromodulators involved in the pathophysiology of suicidal behavior and major affective disorders

  2015cites this paper
• DPP4-deficient congenic rats display blunted stress, improved fear extinction and increased central NPY.

  2015cites this paper
• INVESTIGATING THE ROLE OF NEUROPEPTIDE Y IN THE VENTRAL HIPPOCAMPUS IN REGULATING RATS' ELEVATED PLUS-MAZE AND SHOCK-PROBE BURYING BEHAVIOURS

  2015cites this paper
• NPY Signaling Inhibits Extended Amygdala CRF Neurons to Suppress Binge Alcohol Drinking

  2015cites this paper
• The Diversity of Mechanisms Influenced by Transthyretin in Neurobiology: Development, Disease and Endocrine Disruption

  2015cites this paper
• Neuropeptide Y receptor gene expression in the primate amygdala predicts anxious temperament and brain metabolism.

  2014cites this paper
• Targeting the neuropeptide Y system in stress-related psychiatric disorders

  2014cites this paper
• Molecular underpinnings of anxiety regulation: Novel insights into the role of the purinergic and oxytocinergic systems within the paraventricular nucleus of the hypothalamus

  2014cites this paper
• Modulation of orexigenic and anorexigenic peptides gene expression in the rat DVC and hypothalamus by acute immobilization stress

  2014cites this paper
• Stress, Anxiety, and Cocaine Abuse

  2014cites this paper
• Serum neuropeptide Y in accident survivors with depression or posttraumatic stress disorder.

  2014cites this paper
• Molecular mechanisms of the synaptic and cognitive effects of ghrelin

  2014cites this paper
• Investigating the role of Neuropeptide Y infusions to the dorsal hippocampus in mediating behaviour in several animal models of anxiety

  2014cites this paper
• Central Amygdala Neuroplasticity in Alcohol Dependence

  2014cites this paper
• Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice.

  2014cites this paper
• Anxiolytic-like effects after vector-mediated overexpression of neuropeptide Y in the amygdala and hippocampus of mice.

  2014cites this paper
• Genetic Dissection of Quantitative Trait Loci for Substances of Abuse

  2013cites this paper
• Taking two to tango: a role for ghrelin receptor heterodimerization in stress and reward

  2013cites this paper
• Lateral septal infusions of the neuropeptide Y Y2 receptor agonist, NPY(13-36) differentially affect different defensive behaviors in male, Long Evans rats.

  2013cites this paper
• The Role of Neuropeptides in Suicidal Behavior: A Systematic Review

  2013cites this paper
• NUCB2/nesfatin-1 is associated with elevated scores of anxiety in female obese patients.

  2013cites this paper
• Neuropeptides and hippocampal neurogenesis.

  2013cites this paper
• Metabolic disturbances connecting obesity and depression

  2013cites this paper
• Unraveling the Mechanisms Responsible for the Comorbidity between Metabolic Syndrome and Mental Health Disorders

  2013cites this paper
• Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats.

  2013cites this paper
• Effects of sex and deletion of neuropeptide Y2 receptors from GABAergic neurons on affective and alcohol drinking behaviors in mice

  2013influential citation
• Stress and neuroinflammation.

  2013cites this paper
• Concurrent modulation of extracellular levels of noradrenaline and cAMP during stress and by anxiogenic- or anxiolytic-like neuropeptides in the prefrontal cortex of awake rats.

  2013cites this paper
• Neuropeptide Y (NPY) in the central nucleus of the amygdala (CeA) does not affect ethanol-reinforced responding in binge-drinking, nondependent rats.

  2012cites this paper